结外NK/T细胞淋巴瘤-话题@MedSci

#结外NK/T细胞淋巴瘤#

1篇内容 | 1041人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2233722, encodeId=74492233e224a, content=<a href='/topic/show?id=5b268e8387b' target=_blank style='color:#2F92EE;'>#药物组合#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a>, objectTitle=中国多中心研究探索哪种化疗联合放疗治疗结外NK/T细胞淋巴瘤最优, objectType=article, longId=848774, objectId=5b44848e74f3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240711/1720669414779_5579292.png, objectUrl=/article/show_article.do?id=5b44848e74f3, replyNumber=0, likeNumber=19, createdTime=2024-10-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=5b44848e74f3, moduleTitle=中国多中心研究探索哪种化疗联合放疗治疗结外NK/T细胞淋巴瘤最优, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5b44848e74f3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2222070, encodeId=365b22220e007, content=<a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=87771146e18e' target=_blank style='color:#2F92EE;'>#ENKTL#</a>, objectTitle=【Haematologica】新桥医院血液科开发初诊结外NK/T细胞淋巴瘤的新型预后模型, objectType=article, longId=840053, objectId=6985840053c9, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240821/1724205043049_8538692.jpg, objectUrl=/article/show_article.do?id=6985840053c9, replyNumber=0, likeNumber=55, createdTime=2024-08-23, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6985840053c9, moduleTitle=【Haematologica】新桥医院血液科开发初诊结外NK/T细胞淋巴瘤的新型预后模型, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6985840053c9)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2207144, encodeId=7743220e1447c, content=<a href='/topic/show?id=d38c905431c' target=_blank style='color:#2F92EE;'>#西达苯胺#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=信迪利单抗联合西达苯胺在复发/难治性结外NK/T细胞淋巴瘤中的Ib/II期研究, objectType=article, longId=825977, objectId=1c188259e77c, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240527/1716793947080_5579292.png, objectUrl=/article/show_article.do?id=1c188259e77c, replyNumber=0, likeNumber=134, createdTime=2024-05-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1c188259e77c, moduleTitle=信迪利单抗联合西达苯胺在复发/难治性结外NK/T细胞淋巴瘤中的Ib/II期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c188259e77c)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2205701, encodeId=5f212205e01cb, content=<a href='/topic/show?id=634d90542d9' target=_blank style='color:#2F92EE;'>#西达本胺#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a> <a href='/topic/show?id=87771146e18e' target=_blank style='color:#2F92EE;'>#ENKTL#</a>, objectTitle=STTT：信迪利单抗+西达本胺治疗复发/难治ENKTL的I/II期SCENT研究, objectType=article, longId=826676, objectId=3cba8266e6a3, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240520/1716187063136_5579292.jpg, objectUrl=/article/show_article.do?id=3cba8266e6a3, replyNumber=0, likeNumber=121, createdTime=2024-05-20, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=3cba8266e6a3, moduleTitle=STTT：信迪利单抗+西达本胺治疗复发/难治ENKTL的I/II期SCENT研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3cba8266e6a3)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2197043, encodeId=9e5c219e043b0, content=<a href='/topic/show?id=e13a13585eb' target=_blank style='color:#2F92EE;'>#P-Gemox#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=329c2e376fa' target=_blank style='color:#2F92EE;'>#信迪利单抗#</a>, objectTitle=Lancet Haematol：信迪利单抗联合P-GEMOX一线治疗晚期ENKTL的多中心、单臂、2期研究, objectType=article, longId=820235, objectId=1e508202353d, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668017232524_4754896.png, objectUrl=/article/show_article.do?id=1e508202353d, replyNumber=0, likeNumber=99, createdTime=2024-04-05, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1e508202353d, moduleTitle=Lancet Haematol：信迪利单抗联合P-GEMOX一线治疗晚期ENKTL的多中心、单臂、2期研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1e508202353d)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2189343, encodeId=b3f321893431c, content=<a href='/topic/show?id=f6435e4216a' target=_blank style='color:#2F92EE;'>#放疗#</a> <a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a> <a href='/topic/show?id=187a6e9803' target=_blank style='color:#2F92EE;'>#ENKTCL#</a>, objectTitle=I-II期ENKTL患者3剂量梯度同步调强放疗的2期临床试验：生存和生活质量的长期结果, objectType=article, longId=811577, objectId=04988115e76f, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20221109/1668021554762_4754896.jpeg, objectUrl=/article/show_article.do?id=04988115e76f, replyNumber=0, likeNumber=126, createdTime=2024-02-25, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=04988115e76f, moduleTitle=I-II期ENKTL患者3剂量梯度同步调强放疗的2期临床试验：生存和生活质量的长期结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04988115e76f)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=808976, encodeId=53638089e64e, content=免疫<a href='/topic/show?id=81bae855273' target=_blank style='color:#2F92EE;'>#结外NK/T细胞淋巴瘤#</a>, objectTitle=Blood：Avelumab治疗复发性/难治性结外NK/T细胞淋巴瘤, objectType=article, longId=199475, objectId=ce771994e50b, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/2020814/1597393559816_2110107.PNG, objectUrl=/article/show_article.do?id=ce771994e50b, replyNumber=0, likeNumber=166, createdTime=2020-08-14, rootId=0, userName=lovetcm, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ce771994e50b, moduleTitle=Blood：Avelumab治疗复发性/难治性结外NK/T细胞淋巴瘤, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ce771994e50b)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

结外NK/T细胞淋巴瘤

2020-05-29

梅斯管理员 (审核中...)

前往app查看评论内容

#药物组合# #结外NK/T细胞淋巴瘤#

中国多中心研究探索哪种化疗联合放疗治疗结外NK/T细胞淋巴瘤最优

2024-10-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#结外NK/T细胞淋巴瘤# #ENKTL#

【Haematologica】新桥医院血液科开发初诊结外NK/T细胞淋巴瘤的新型预后模型

2024-08-23发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#西达苯胺# #结外NK/T细胞淋巴瘤# #信迪利单抗#

信迪利单抗联合西达苯胺在复发/难治性结外NK/T细胞淋巴瘤中的Ib/II期研究

2024-05-28发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#西达本胺# #结外NK/T细胞淋巴瘤# #信迪利单抗# #ENKTL#

STTT：信迪利单抗+西达本胺治疗复发/难治ENKTL的I/II期SCENT研究

2024-05-20发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#P-Gemox# #结外NK/T细胞淋巴瘤# #信迪利单抗#

Lancet Haematol：信迪利单抗联合P-GEMOX一线治疗晚期ENKTL的多中心、单臂、2期研究

2024-04-05发表于上海

梅斯管理员 (审核中...)

前往app查看评论内容

#放疗# #结外NK/T细胞淋巴瘤# #ENKTCL#

I-II期ENKTL患者3剂量梯度同步调强放疗的2期临床试验：生存和生活质量的长期结果

2024-02-25发表于上海

lovetcm (审核中...)

前往app查看评论内容

免疫#结外NK/T细胞淋巴瘤#

Blood：Avelumab治疗复发性/难治性结外NK/T细胞淋巴瘤

2020-08-14

科室
- - 订阅+
  - 更多科室
工具
服务